Live Breaking News & Updates on Gastroesophageal Cancers

Share:
HONG KONG and SHANGHAI, Dec. 16, 2020 /PRNewswire/ Ping An Insurance (Group) Company of China, Ltd. (hereafter Ping An or the Group , HKEX: 02318; SSE: 601318) announced the launch of the artificial intelligence (AI) assisted clinical decision support system (CDSS), AskBob Cancer for Gastroesophageal Cancers, developed by Ping An, National University Hospital, Singapore (NUH) and National University Cancer Institute of Singapore (NCIS).
The launch took place at the Singapore Healthcare AI Expo 2020 which is organized by National University of Singapore, National University Health System and MIT Critical Data.
AskBob Doctor is an innovative breakthrough in the field of AI tumor management. Dr. Guotong Xie, Chief Healthcare Scientist of Ping An and Prof. Jimmy So, Head and Senior Consultant, Division of Surgical Oncology, NCIS, gave a live demonstration of the AskBob Cancer system to showcase how it helps oncologists make more accurate and efficient decision ....

National University Hospital , Singapore General , Ping An , Hong Kong , National University Of Singapore , Guotong Xie , Millward Brown Brand , National University Health System , National University Cancer Institute Of Singapore , Ping An Group , Division Of Surgical Oncology , Askbob Cancer , Gastroesophageal Cancers , National University Cancer Institute , Singapore Healthcare , National University , Bob Doctor , Chief Healthcare Scientist , Senior Consultant , Surgical Oncology , Bob Cancer , Forbes Global , Fortune Global , Millward Brown , Valuable Global Brands , தேசிய பல்கலைக்கழகம் மருத்துவமனை ,